RP-1486

N/A

Report date: 2025/01/26 17:56:58
NME

Base Information

Drug NameRP-1486
Drug Alias Namemitochondrial targetting anticancer agent (New Use Therapeutics)RP-1486
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNew Use Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDrugs With A Difference Ltd
Inactive CompaniesNew Use Therapeutics Ltd
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A